Font Size:
a
A
A
Keyword [Nucleos(t)ide analogue]
Result: 1 - 20 | Page: 1 of 2
1.
Drug Resistance During Sequential Therapy Of Nucleos(t)ide Analogue In The Treatment Of Chronic Hepatitis B
2.
The Impact Of Nucleos(T)ide Analogue Antiviral Therapy On Anxiety And Depression Of Patients With Chronic Hepiatitis B
3.
Mutation Analysis Of The HBV Reverse Transcriptase In Nucleos(t)Ide-treatedpatients With Chronic HBV Infection
4.
Treatment With Nucleos(t)ide Analogue And Thymosin Alpha-1Versus Nucleos(t)ide Analogue Monotherapy For HBeAg-positive Chronic Hepatitis B: A Meta-analysis
5.
The Kinetics Of HBsAg During Long Term Nucleos(t)Ide Analogue Treatment In Chronic Hepatitis B Patients
6.
The Expression And Clinical Significance Of Interleukin-21 After Discontinuation Of Nucleos(t)ide Analogue Therapy In Patients With Chronic Hepatitis B
7.
Molecular Epidemiology Study Of The Genotypic Mutations Conferring Resistance To Nucleos(t)ide Analogues From Clinical Specimens Of Patients With Hepatitis B
8.
Analysis On RtA181T Mutant In HBV Related And Hepatocellular Carcinoma In Patients With Liver Cirrhosis
9.
The Prediction Of Virological Relapse And Clinical Relapse After Nucleos(t)ide Analogue Discontinuation:A Prospective Study
10.
Cost-effectiveness Analysis Of Nucleos(t)ide Analogue Monotherapies And Initial Combination Treatment For Chinese HBeAg-positive Chronic Hepatitis B Patients
11.
Efficacy Of Fuzhenghuayu Capsules Combined With Nucleos(t)ide Analogue In Patients With Hepatitis B Cirrhosis Compensatory Phase
12.
Clinical Outcomes Of Nucleos(t)ide Analogue Resistance And Pre-existing Drug Resistance In The Hepatitis B Virus-related Hepatocellular Carcinoma Patients After Radical Resection
13.
Cost-effectiveness Analysis Of Nucleos(t)ide Analogue Treatments For Chronic Hepatitis B Patients
14.
The Impact Of Nucleos(t)ide Analogues On EGFR In Patients With Chronic HBV Infection
15.
Association Of Natural Killer And Hepatitis B Virus-specific T Cells With Virologic Relapse And Liver Damage After Nucleos(t)ide Analogue Cessation
16.
Corelation Between CXCL13/CXCR5 Expression And Clinical Relapse After Nucleos(t)ide Analogue Discontinuation In Chronic Hepatitis B Patients
17.
Elevated Expression Of Serum Soluble ST2 In Clinical Relapse After Stopping Long-term Nucleos(t)ide Analogue Therapy For Chronic Hepatitis B
18.
Analysis Of Variation After Treatment With Nucleos(t) Ide Analogue In Patients With Chronic Hepatitis B
19.
Study On The Efficacy And Evolutionary Patterns Of HBV In Patients With Chronic Hepatitis B During Nucleot(s)ide Analog Therapy
20.
Long-term Outcomes Of Antiviral Therapy And Relationship Between Changes Of HBsAg Kinetics And Host Adaptive Immunity In Chronic Hepatitis B Patients
<<First
<Prev
Next>
Last>>
Jump to